Several reports studying the role of B cells in the context of non-small cell lung cancer (NSCLC) have shown that upregulation of B cell related genes (3), CD20+ B cell infiltration (4), and the presence of B cell in tertiary lymphoid structures (TLS) correlated with patient survival, suggesting B cells role in tumor control. This evidence concerns the gene MS4A1 and non-small cell lung carcinoma.